Cite
HARVARD Citation
Li, P. et al. (2022). Association of dipeptidyl peptidase-4 inhibitor use and the risk of asthma development among type 2 diabetes patients. Therapeutic advances in respiratory disease. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Li, P. et al. (2022). Association of dipeptidyl peptidase-4 inhibitor use and the risk of asthma development among type 2 diabetes patients. Therapeutic advances in respiratory disease. p. . [Online].